CIK 0001810560 · Non-accelerated filer<br>Smaller reporting company
REVELATION BIOSCIENCES, INC.
Sign in to watch- Ticker
- REVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843898466
- Phone
- 650-800-3717
- Business address
- 4660 LAJOLLA VILLAGE DRIVE, SUITE 100, SAN DIEGO, CA, 92122
- Former names
- Petra Acquisition Inc.
Securities
- REVB Common Stock Nasdaq
- REVBW Warrant Nasdaq
- 8-K Event Regulation FD disclosure
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Shareholder vote results
- SC 13G Stake Amended Statement of Ownership
- UPLOAD Other SEC-generated Letter
- DEF 14A Proxy Proxy Statement
- S-1 Offering Registration Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Insider Changes in Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Regulation FD disclosure · Other events
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
Page 9 of 20 · 389 filings